Tryptophan Metabolites in the Progression of Liver Diseases
The aim of this study was to investigate the levels of various tryptophan metabolites in patients with alcoholic liver disease (ALD) and metabolic-associated fatty liver disease (MAFLD) at different stages of the disease. The present study included 44 patients diagnosed with MAFLD, 40 patients diagn...
Saved in:
| Main Authors: | Maria Reshetova, Pavel Markin, Svetlana Appolonova, Ismail Yunusov, Oksana Zolnikova, Elena Bueverova, Natiya Dzhakhaya, Maria Zharkova, Elena Poluektova, Roman Maslennikov, Vladimir Ivashkin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/14/11/1449 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01) -
Different fungal signatures in ALD and MAFLD
by: Daya Zhang, et al.
Published: (2024-11-01) -
Tryptophan as a biomarker of pregnancy-related immune expression and modulation: an integrative review
by: Stephanie Prescott, et al.
Published: (2025-01-01) -
Statin Monotherapy Not Inferior to Aspirin or Combined Aspirin and Statins Reducing the Incidences of Cirrhosis, HCC, and Mortality in MAFLD/MASH Patients: A Population Cohort Study
by: Lee CH, et al.
Published: (2024-12-01) -
STUDY OF L-TRYPTOPHAN IN AN EXPERIMENTAL MODEL OF DEPRESSION CAUSED BY ALZHEIMER’S DISEASE
by: Andressa Leticia Miri, et al.
Published: (2017-10-01)